---
title: "National People's Congress representative and Chairman of Kanion Pharmaceutical, Xiao Wei: Classic Chinese medicine formulas need to be \"awakened\" and also \"renewed\""
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/230833547.md"
description: "Xiao Wei, a representative of the National People's Congress and chairman of Kanion Pharmaceutical, proposed at the 2025 National Two Sessions that classic Chinese medicine formulas need to adapt to modern medical needs, emphasizing the need to not only \"awaken\" but also \"renew.\" He stressed the importance of strengthening basic research, focusing on effective substances, promoting the research and development of new drugs based on classic formulas, and ensuring their safety and efficacy. In addition, Xiao Wei suggested implementing quality control through the QbD concept to ensure the quality of traditional Chinese medicine is uniform, stable, and controllable"
datetime: "2025-03-06T13:10:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/230833547.md)
  - [en](https://longbridge.com/en/news/230833547.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/230833547.md)
generator: "portal-rs"
---

# National People's Congress representative and Chairman of Kanion Pharmaceutical, Xiao Wei: Classic Chinese medicine formulas need to be "awakened" and also "renewed"

At the 2025 National Two Sessions, Xiao Wei, a representative of the National People's Congress, an academician of the Chinese Academy of Engineering, and chairman of Kanion Pharmaceutical, focused his suggestions on the field of classic Chinese medicine formulas. In Xiao Wei's view, to meet modern medical needs, ancient classic Chinese medicine formulas not only need to be "awakened" but also need to be "renewed." Regarding the classic formulas' "what components are effective and why they are effective," Xiao Wei believes that basic research centered on effective substances should be strengthened. Moreover, the research and development of new drugs based on classic formulas must focus on clinically effective material foundations to further analyze the effective substances and targets of the complex system of Chinese medicine, scientifically explaining the safety and efficacy of new drugs based on classic formulas. In terms of Chinese medicine manufacturing, Xiao Wei suggests that the QbD (Quality by Design) concept should be the core, using the effective components in classic formulas as quality control indicators, implementing instantaneous control of "points" from process technology to quality control standards, as well as control adjustments between "segments" of processes, and ensuring consistency in quality between "batches," fundamentally guaranteeing the uniformity, stability, and controllability of traditional Chinese medicine products

### Related Stocks

- [600557.CN](https://longbridge.com/en/quote/600557.CN.md)
- [562390.CN](https://longbridge.com/en/quote/562390.CN.md)

## Related News & Research

- [15:10 ETHas Anyone Tried Gundry MD Vital Reds? Read Reviews, Ingredients, Benefits & More](https://longbridge.com/en/news/297553063.md)
- [Women accounted for almost all of job gains in August. Here's why](https://longbridge.com/en/news/298065115.md)
- [12:09 ETHaier Biomedical präsentiert automatisierte Biolagerung und vernetzte Pharma-Lösungen auf der ISPE Singapore 2026](https://longbridge.com/en/news/297810393.md)
- [South Korea reviewing options to support Hormuz navigation, official says](https://longbridge.com/en/news/297980209.md)
- [Mabwell reports Phase Ib/IIa data showing anti-ST2 antibody 9MW1911 cuts COPD exacerbations up to 81%](https://longbridge.com/en/news/298042457.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**